Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.24.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Jun. 29, 2024
Jul. 01, 2023
Income Statement [Abstract]        
Net revenue $ 5,835 $ 5,359 $ 11,308 $ 10,712
Cost of sales 2,740 2,704 5,423 5,393
Amortization of acquisition-related intangibles 231 212 461 517
Cost of sales 2,971 2,916 5,884 5,910
Gross profit 2,864 2,443 5,424 4,802
Research and development 1,583 1,443 3,108 2,854
Marketing, general and administrative 650 547 1,270 1,132
Amortization of acquisition-related intangibles-Opex 372 481 764 999
Licensing gain (10) (8) (23) (18)
Operating income (loss) 269 (20) 305 (165)
Interest expense (25) (28) (50) (53)
Other income (expense), net 55 46 108 89
Income (loss) before income taxes and equity income 299 (2) 363 (129)
Income tax provision (benefit) 41 (23) (11) (10)
Equity income in investee 7 6 14 7
Net income (loss) $ 265 $ 27 $ 388 $ (112)
Earnings (loss) per share        
Basic (in usd per share) $ 0.16 $ 0.02 $ 0.24 $ (0.07)
Diluted (in usd per share) $ 0.16 $ 0.02 $ 0.24 $ (0.07)
Shares used in per share calculation        
Basic (in shares) 1,618 1,612 1,617 1,612
Diluted (in shares) 1,637 1,627 1,638 1,612